BioSpace News Archive

High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size to Reach USD 32.11 Billion in 2028

Increasing preference for outsourcing of HPAPI manufacturing and rich pipeline with targeted therapeutic drugs would drive market growth.

June 17, 2021
·
4 min read
Molecular Diagnostics Market to Reach USD 16.16 Billion by 2028, Noted Reports and Data

Technological advancements in molecular testing techniques and increasing prevalence of different types of cancer and neurological disorders are key factors fueling global market growth.

June 17, 2021
·
6 min read
Ovarian Cancer Diagnostics Market Size to Reach USD 2.3 Billion in 2028, Says Reports and Data

Rising prevalence of ovarian cancer and growing focus on early detection and treatment are expected to fuel market growth.

June 17, 2021
·
5 min read
Deals

Century Therapeutics Announces Pricing of Initial Public Offering

Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the pricing of its initial public offering of 10,550,000 shares of its common stock at a public offering price of $20.00 per share

June 17, 2021
·
3 min read
Deals

Cyteir Therapeutics Announces Pricing of Initial Public Offering

Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT), today announced the pricing of its initial public offering of 7,400,000 shares of its common stock at an initial public offering price of $18.00 per share

June 17, 2021
·
4 min read
Cell Viability Assays Market Size to Reach USD 6.35 Billion in 2028, Says Reports and Data

Rising use of cell viability assays in evaluation of drug safety and efficacy, increasing use in quality control experiments, and rising focus on cell-based therapeutics to treat chronic illnesses are key factors driving market growth.

June 17, 2021
·
6 min read
Electronic Clinical Outcome Assessment (eCOA) Solution Market to Reach USD 3.48 Billion By 2028

Increasing focus on digitalizing the process of medical clinical trial outcomes coupled with advancements in eCOA applications are key factors driving market growth.

June 17, 2021
·
5 min read
Business

Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial

Diamond Therapeutics Inc. is pleased to announce the selection of BioPharma Services Inc. as the contract research organization (CRO) for its Phase 1 clinical trial.

June 17, 2021
·
4 min read
FDA

Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer

Turning Point Therapeutics, Inc. today announced that TPX-0022, the company’s inhibitor of MET has been granted orphan drug designation by the Food and Drug Administration (FDA) for the treatment of patients with gastric cancer.

June 17, 2021
·
4 min read
Biotech Bay

AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional Materials

AcelRx Pharmaceuticals, Inc. , today announced it has reached agreement with the Food and Drug Administration (FDA) with regards to finalizing corrective actions in a warning letter.

June 17, 2021
·
4 min read